ALEC Alector, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$1,81
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$1,0952-Wochen-Tief
$3,4052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$202M
P/E (TTM)
-1.6
EPS (TTM)
$-1.10
Umsatz (TTM)
$14M
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
BUY
Kursziel
$3
P/E
-1.6
ROE
-385.1%
Nettogewinnmarge
-851.7%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ALEC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$1.81
Marktkapitalisierung (MRQ)
$202M
P/E (TTM)
-1.6
EPS (TTM)
$-1.10
Umsatz (TTM)
$14M
ROE (TTM)
-385.1%
Verschuldungsgrad (MRQ)
-1.0
52W-Spanne
$1–$3
ALEC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Alector, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter103
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$21M2017-12-31 → 2025-12-31
EPS$-1.392020-12-31 → 2025-12-31
Freier Cashflow$-184M2019-12-31 → 2025-12-31
Nettogewinnmarge-851.7%2019-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ALEC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.65-Jahres-Durchschnitt ≈-11.9 | ≈-11.9 | · | · | |
| P/S (TTM) | 14.65-Jahres-Durchschnitt ≈6.1 | ≈6.1 | 16.0 | Überbewertet | |
| K/B (MRQ) | -20.35-Jahres-Durchschnitt ≈4.2 | ≈4.2 | · | · | |
| EV / EBITDA | 0.3 | · | · | · | |
| Kurs / FCF (TTM) | -1.35-Jahres-Durchschnitt ≈-6.2 | ≈-6.2 | · | · | |
| Kurs / Cashflow (TTM) | -1.35-Jahres-Durchschnitt ≈-7.4 | ≈-7.4 | · | · | |
| EV / Umsatz (TTM) | 2.8 | · | · | · | |
| EV / FCF (TTM) | -0.2 | · | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 6.65-Jahres-Durchschnitt ≈4.2 | ≈4.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ALEC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -914.1%5-Jahres-Durchschnitt ≈-232.6% | ≈-232.6% | -1357.2% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -741.3%5-Jahres-Durchschnitt ≈-232.6% | ≈-232.6% | -1356.6% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -849.4% | · | -1167.4% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -851.7%5-Jahres-Durchschnitt ≈-209.8% | ≈-209.8% | -1615.2% | Spitzenklasse | |
| ROA (TTM) | -42.1%5-Jahres-Durchschnitt ≈-20.0% | ≈-20.0% | -24.7% | Schwach | |
| ROE (TTM) | -385.1%5-Jahres-Durchschnitt ≈-106.8% | ≈-106.8% | -24.6% | Schwach | |
| ROIC | -387.2% | · | -51.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ALEC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | -1.0 | · | -0.2 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 5.35-Jahres-Durchschnitt ≈4.7 | ≈4.7 | 7.9 | Geringe Liquidität | |
| Quick Ratio | 3.75-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 7.4 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | -0.0 | · | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ALEC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -79.1%5-Jahres-Durchschnitt ≈148.6% | ≈148.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -46.0%5-Jahres-Durchschnitt ≈-0.35% | ≈-0.35% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -0.05% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ALEC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$204.3K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
22.4%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.21 | $-0.23 | 9.7% |
| 31. März 2026 | $-0.21 | $-0.35 | 39.9% | |
| 31. Dezember 2025 | $-0.34 | $-0.39 | 13.1% | |
| 30. September 2025 | $-0.34 | $-0.42 | 18.2% | |
| 30. Juni 2025 | $-0.30 | $-0.47 | 36.1% | |
| 31. März 2025 | $-0.41 | $-0.49 | 17.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21M | $101M | $97M | $134M | $207M | $21M | $21M | $28M | |
| R&D Expense | $123M | $186M | $192M | $210M | $189M | $157M | $101M | $73M | |
| SG&A Expense | $54M | $60M | $57M | $61M | $55M | $59M | $35M | $12M | |
| Operating Expenses | $177M | $246M | $249M | $271M | $244M | $216M | $136M | $85M | |
| Operating Income | $-156M | $-145M | $-152M | $-138M | $-37M | $-195M | $-114M | $-57M | |
| Other Non-op | $13M | $26M | $27M | $8M | $1M | $5M | $9M | $5M | |
| Pretax Income | $-143M | $-119M | $-125M | $-130M | · | · | · | · | |
| Income Tax | $168.0K | $128.0K | $5M | $3M | $0 | $0 | $0 | · | |
| Net Income | $-143M | $-119M | $-130M | $-133M | $-36M | $-190M | $-105M | $-52M | |
| EPS (Basic) | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 | $-2.45 | · | · | |
| EPS (Diluted) | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 | $-2.45 | · | · | |
| Shares (Basic) | 102,998,978 | 96,588,177 | 83,733,730 | 82,467,587 | 80,416,936 | 77,758,806 | · | · | |
| Shares (Diluted) | 102,998,978 | 96,588,177 | 83,733,730 | 82,467,587 | 80,416,936 | 77,758,806 | · | · | |
| EBITDA | $-156M | $-145M | $-152M | $-138M | $-37M | · | $-114M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $66M | $33M | $75M | $154M | $329M | $50M | $90M | $65M | |
| Short-term Investments | $190M | $380M | $474M | $559M | $406M | $363M | $263M | $225M | |
| Prepaid Expense | $10M | $11M | $17M | $11M | $7M | $8M | $4M | $3M | |
| Current Assets | $266M | $425M | $566M | $726M | $750M | $422M | $357M | $293M | |
| PP&E (Net) | $11M | $17M | $22M | $26M | $27M | $30M | $34M | $11M | |
| PP&E (Gross) | $48M | $50M | $50M | $48M | $45M | $41M | $39M | $13M | |
| Accum. Depreciation | $37M | $33M | $28M | $23M | $17M | $11M | $5M | $2M | |
| Other Non-current Assets | $386.0K | $5M | $7M | $6M | $6M | $3M | $676.0K | $3M | |
| Total Assets | $293M | $468M | $622M | $788M | $815M | $488M | $422M | $308M | |
| Accounts Payable | $2M | $2M | $4M | $4M | $5M | $3M | $278.0K | $126.0K | |
| Accrued Liabilities | $19M | $29M | $30M | $28M | $27M | $23M | $18M | $8M | |
| Short-term Debt | $366.0K | $0 | · | · | · | · | · | · | |
| Current Liabilities | $70M | $125M | $178M | $94M | $140M | $68M | $62M | $48M | |
| Capital Leases | $17M | $24M | $30M | $35M | $40M | $44M | $41M | · | |
| Other Non-current Liabilities | $2M | $1M | $1M | $759.0K | $158.0K | $472.0K | $493.0K | $96.0K | |
| Total Liabilities | $263M | $342M | $488M | $573M | $514M | $221M | $227M | $195M | |
| Long-term Debt | $10M | $10M | · | · | · | · | · | · | |
| Total Debt | $10M | $9M | · | · | · | · | · | · | |
| Common Stock | $11.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $1.0K | |
| Paid-in Capital | $1.00B | $956M | $844M | $799M | $748M | $677M | $414M | $17M | |
| Retained Earnings | $-972M | $-829M | $-710M | $-580M | $-446M | $-410M | $-220M | $-114M | |
| AOCI | $166.0K | $261.0K | $184.0K | $-5M | $-943.0K | $614.0K | $142.0K | $-42.0K | |
| Stockholders' Equity | $31M | $127M | $134M | $214M | $301M | $268M | $195M | $-97M | |
| Liabilities + Equity | $293M | $468M | $622M | $788M | $815M | $488M | $422M | $308M | |
| Shares Outstanding | 110,362,581 | 99,085,888 | 84,879,693 | 82,895,718 | 81,986,192 | 79,316,261 | 69,052,873 | 13,764,829 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $6M | $6M | $6M | $6M | $4M | $1M | |
| Stock-based Comp | $27M | $39M | $43M | $46M | $41M | $31M | $16M | $7M | |
| Restructuring | $2M | $4M | $2M | · | · | · | · | · | |
| Operating Cash Flow | $-184M | $-230M | $-184M | $-20M | $299M | $-167M | $-99M | $127M | |
| CapEx | $41.0K | $1M | $2M | $4M | $3M | $5M | $15M | $2M | |
| Investing Cash Flow | $197M | $107M | $102M | $-159M | $-50M | $-105M | $-49M | $-224M | |
| Stock Issued | $20M | $71M | · | · | · | · | · | · | |
| Net Stock Activity | $20M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $20M | $82M | $3M | $5M | $30M | $232M | $172M | $131M | |
| Net Change in Cash | $33M | $-41M | $-80M | $-175M | $279M | $-40M | $24M | $34M | |
| Taxes Paid | $-880.0K | $-100.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-184M | $-231M | $-187M | $-24M | $295M | · | $-115M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -741.3% | -144.1% | -156.3% | -103.2% | -18.0% | · | -539.2% | · | |
| Net Margin | -679.2% | -118.3% | -134.3% | -99.8% | -17.5% | · | -496.6% | · | |
| Pretax Margin | -678.4% | -118.2% | · | · | · | · | · | · | |
| EBITDA Margin | -741.3% | -144.1% | -156.3% | -103.2% | -18.0% | · | -539.2% | · | |
| ROA | -37.5% | -21.8% | -18.5% | -16.6% | -5.6% | · | -28.9% | · | |
| ROE | -280.7% | -96.9% | -87.9% | -57.0% | -11.4% | · | -51.0% | · | |
| ROIC | -387.2% | -106.6% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.4 | 3.2 | 7.7 | 5.4 | · | 5.8 | · | |
| Quick Ratio | 3.7 | 3.3 | 3.1 | 7.6 | 5.3 | · | 5.7 | · | |
| Debt / Equity | 0.3 | 0.1 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.3 | 0.1 | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.2 | 0.1 | 0.2 | 0.3 | · | 0.1 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | $1.28 | $1.58 | $2.62 | $3.79 | · | $2.82 | · | |
| Revenue / Share | $0.20 | $1.04 | $1.16 | $1.62 | · | · | · | · | |
| Cash Flow / Share | $-1.79 | $-2.38 | $-2.20 | $-0.25 | · | · | · | · | |
| Cash / Share | $0.60 | $0.33 | $0.88 | $1.88 | $4.15 | · | $1.30 | · | |
| EPS (TTM) | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 | $-2.45 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -79.1% | 3.6% | -27.3% | -35.5% | 881.5% | · | · | · | |
| Revenue CAGR 3Y | -46.0% | -21.4% | 66.3% | · | · | · | · | · | |
| Revenue CAGR 5Y | -0.05% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $21M | $101M | $97M | $134M | $207M | $21M | $21M | $28M | |
| Net Income TTM | $-143M | $-119M | $-130M | $-133M | $-36M | $-190M | $-105M | $-52M | |
| Market Cap | $172M | $187M | $677M | $757M | $1.64B | · | $1.19B | · | |
| Enterprise Value | $-74M | $-217M | · | · | · | · | · | · | |
| P/E | -1.1 | -1.5 | -5.1 | -5.7 | -45.9 | -6.2 | · | · | |
| P/S | 8.2 | 1.9 | 7.0 | 5.7 | 7.9 | · | 56.1 | · | |
| P/B | 5.6 | 1.5 | 5.0 | 3.5 | 5.4 | · | 6.1 | · | |
| P / Tangible Book | 5.6 | 1.5 | 5.0 | 3.5 | 5.4 | 4.5 | · | · | |
| P / Cash Flow | -0.9 | -0.8 | -3.7 | -37.2 | 5.5 | · | -12.0 | · | |
| P / FCF | -0.9 | -0.8 | -3.6 | -31.0 | 5.5 | · | -10.4 | · | |
| EV / EBITDA | 0.5 | 1.5 | · | · | · | · | · | · | |
| EV / FCF | 0.4 | 0.9 | · | · | · | · | · | · | |
| EV / Revenue | -3.5 | -2.2 | · | · | · | · | · | · | |
| Earnings Yield | -89.1% | -65.1% | -19.6% | -17.5% | -2.2% | -16.2% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $1M | $6M | $3M | $8M | $4M | $54M | $15M | $15M | $16M | $15M | $9M | $56M | $17M | $14M | $15M | |
| R&D Expense | $19M | $18M | $32M | $29M | $28M | $34M | $46M | $48M | $46M | $45M | $48M | $46M | $46M | $52M | $54M | $48M | |
| SG&A Expense | $8M | $8M | $13M | $12M | $14M | $15M | $15M | $16M | $14M | $14M | $15M | $13M | $14M | $15M | $15M | $14M | |
| Operating Expenses | $28M | $26M | $46M | $41M | $42M | $48M | $61M | $64M | $61M | $60M | $63M | $60M | $60M | $67M | $70M | $63M | |
| Operating Income | $-24M | $-25M | $-40M | $-38M | $-34M | $-45M | $-7M | $-48M | $-46M | $-44M | $-47M | $-51M | $-4M | $-50M | $-55M | $-48M | |
| Other Non-op | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $6M | $7M | $8M | $8M | $7M | $6M | $5M | $4M | $2M | |
| Pretax Income | $-23M | $-23M | $-37M | $-35M | $-31M | $-40M | $-2M | $-42M | $-39M | $-36M | · | · | · | · | · | · | |
| Income Tax | $130.0K | $0 | $168.0K | $0 | $0 | $0 | $48.0K | $0 | $73.0K | $7.0K | $2M | $1M | $1M | $901.0K | $721.0K | $733.0K | |
| Net Income | $-23M | $-23M | $-37M | $-35M | $-31M | $-40M | $-2M | $-42M | $-39M | $-36M | $-41M | $-44M | $1M | $-46M | $-52M | $-46M | |
| EPS (Basic) | $-0.21 | $-0.21 | $-0.34 | $-0.34 | $-0.30 | $-0.41 | $-0.02 | $-0.43 | $-0.40 | $-0.38 | $-0.50 | $-0.53 | $0.02 | $-0.55 | $-0.64 | $-0.56 | |
| EPS (Diluted) | $-0.21 | $-0.21 | $-0.34 | $-0.34 | $-0.30 | $-0.41 | $-0.02 | $-0.43 | $-0.40 | $-0.38 | $-0.50 | $-0.53 | $0.02 | $-0.55 | $-0.64 | $-0.56 | |
| Shares (Basic) | 111,224,116 | 110,590,014 | · | 102,597,601 | 100,371,632 | 99,398,200 | · | 97,519,595 | 96,674,921 | 93,810,177 | · | 83,927,961 | 83,497,125 | 83,102,296 | · | 82,602,842 | |
| Shares (Diluted) | 111,224,116 | 110,590,014 | · | 102,597,601 | 100,371,632 | 99,398,200 | · | 97,519,595 | 96,674,921 | 93,810,177 | · | 83,927,961 | 83,566,293 | 83,102,296 | · | 82,602,842 | |
| EBITDA | $-24M | $-25M | · | $-38M | $-34M | $-45M | · | $-48M | $-46M | $-44M | · | $-51M | $-4M | $-50M | · | $-48M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $60M | $77M | $66M | $77M | $45M | $38M | $33M | $37M | $48M | $73M | $75M | $102M | $132M | $196M | · | $184M | |
| Short-term Investments | $113M | $130M | $190M | $215M | $263M | $317M | $380M | $420M | $456M | $490M | $474M | $487M | $499M | $474M | · | $574M | |
| Prepaid Expense | $7M | $9M | $10M | $9M | $12M | $12M | $11M | $12M | $16M | $19M | $17M | $14M | $10M | $12M | · | $10M | |
| Current Assets | $180M | $215M | $266M | $300M | $319M | $367M | $425M | $469M | $520M | $581M | $566M | $613M | $648M | $686M | · | $775M | |
| PP&E (Net) | $9M | $10M | $11M | $13M | $14M | $16M | $17M | $18M | $20M | $21M | $22M | $23M | $24M | $25M | · | $26M | |
| PP&E (Gross) | · | · | $48M | · | · | · | $50M | · | · | · | $50M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $37M | · | · | · | $33M | · | · | · | $28M | · | · | · | · | · | |
| Other Non-current Assets | $353.0K | $369.0K | $386.0K | $4M | $4M | $5M | $5M | $6M | $6M | $7M | $7M | $9M | $9M | $9M | · | $6M | |
| Total Assets | $203M | $240M | $293M | $335M | $356M | $408M | $468M | $516M | $571M | $635M | $622M | $672M | $709M | $748M | · | $837M | |
| Accounts Payable | $2M | $1M | $2M | $5M | $2M | $2M | $2M | $5M | $4M | $5M | $4M | $5M | $5M | $3M | · | $5M | |
| Accrued Liabilities | $7M | $11M | $19M | $18M | $14M | $17M | $29M | $26M | $23M | $19M | $30M | $30M | $23M | $19M | · | $23M | |
| Short-term Debt | · | $1M | $366.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $34M | $41M | $70M | $80M | $84M | $110M | $125M | $143M | $148M | $165M | $178M | $155M | $132M | $99M | · | $161M | |
| Capital Leases | $14M | $16M | $17M | $19M | $21M | $23M | $24M | $26M | $28M | $29M | $30M | $32M | $33M | $34M | · | $36M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $898.0K | $898.0K | $898.0K | · | $233.0K | |
| Total Liabilities | $213M | $230M | $263M | $278M | $285M | $314M | $342M | $397M | $420M | $457M | $488M | $510M | $512M | $565M | · | $584M | |
| Long-term Debt | $10M | · | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $10M | $10M | · | $10M | $10M | $9M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $11.0K | $11.0K | $11.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | · | $8.0K | |
| Paid-in Capital | $1.01B | $1.01B | $1.00B | $992M | $971M | $964M | $956M | $945M | $936M | $925M | $844M | $832M | $822M | $811M | · | $787M | |
| Retained Earnings | $-1.02B | $-995M | $-972M | $-935M | $-900M | $-870M | $-829M | $-827M | $-785M | $-746M | $-710M | $-669M | $-624M | $-626M | · | $-527M | |
| AOCI | $-126.0K | $-104.0K | $166.0K | $197.0K | $96.0K | $191.0K | $261.0K | $931.0K | $-620.0K | $-403.0K | $184.0K | $-721.0K | $-1M | $-2M | · | $-7M | |
| Stockholders' Equity | $-10M | $10M | $31M | $58M | $71M | $95M | $127M | $119M | $151M | $179M | $134M | $163M | $196M | $183M | $214M | $253M | |
| Liabilities + Equity | $203M | $240M | $293M | $335M | $356M | $408M | $468M | $516M | $571M | $635M | $622M | $672M | $709M | $748M | · | $837M | |
| Shares Outstanding | 111,656,805 | 111,025,187 | 110,362,581 | 107,446,056 | 101,212,329 | 99,992,600 | 99,085,888 | 97,929,897 | 97,321,062 | 96,384,562 | 84,879,693 | 84,136,381 | 83,830,300 | 83,351,778 | 82,895,718 | 81,986,192 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $2M | $984.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Stock-based Comp | $3M | $3M | $5M | $6M | $7M | $8M | $10M | $9M | $10M | $10M | $12M | $10M | $10M | $11M | $11M | $11M | |
| Restructuring | $700.0K | $-300.0K | $100.0K | $-100.0K | $0 | $2M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-34M | $-50M | $-42M | $-33M | $-49M | $-61M | $-55M | $-51M | $-63M | $-61M | $-46M | $-47M | $-43M | $-49M | $-49M | $-49M | |
| CapEx | $31.0K | $118.0K | $0 | $11.0K | $10.0K | $20.0K | $173.0K | $212.0K | $337.0K | $533.0K | $233.0K | $-94.0K | $1M | $1M | $766.0K | $2M | |
| Investing Cash Flow | $17M | $61M | $26M | $50M | $56M | $66M | $41M | $40M | $37M | $-12M | $18M | $17M | $-22M | $89M | $18M | $61M | |
| Stock Issued | · | · | $5M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $50.0K | $25.0K | $5M | $15M | $122.0K | $0 | $10M | $0 | $644.0K | $71M | $590.0K | $0 | $881.0K | $1M | $636.0K | $489.0K | |
| Net Change in Cash | $-17M | $11M | $-11M | $32M | $7M | $5M | $-4M | $-10M | $-25M | $-2M | $-27M | $-30M | $-64M | $41M | $-30M | $12M | |
| Free Cash Flow | · | $-50M | · | · | · | $-61M | · | · | · | $-62M | · | · | · | $-50M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -734.7% | -2382.3% | · | -1153.6% | -433.5% | -1208.0% | · | -315.7% | -302.4% | -275.0% | · | -555.3% | -6.4% | -302.8% | · | -321.5% | |
| Net Margin | -692.5% | -2192.2% | · | -1063.4% | -387.7% | -1093.8% | · | -275.2% | -256.4% | -227.0% | · | -488.2% | 2.5% | -277.1% | · | -310.7% | |
| Pretax Margin | -688.6% | -2192.2% | · | -1063.4% | -387.7% | -1094.6% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -734.7% | -2382.3% | · | -1153.6% | -433.5% | -1208.0% | · | -315.7% | -302.4% | -275.0% | · | -555.3% | -6.4% | -302.8% | · | -321.5% | |
| ROA | -8.2% | -7.1% | · | -8.1% | -6.6% | -7.8% | · | -7.1% | -6.0% | -5.2% | · | -5.9% | 0.17% | -5.4% | · | -5.5% | |
| ROE | -75.1% | -43.7% | · | -39.2% | -27.5% | -29.6% | · | -30.0% | -22.3% | -19.9% | · | -21.4% | 0.57% | -20.4% | · | -15.7% | |
| ROIC | 20108.0% | -123.7% | · | -55.9% | -42.3% | -43.0% | · | · | · | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | 5.3 | · | 3.8 | 3.8 | 3.3 | · | 3.3 | 3.5 | 3.5 | · | 3.9 | 4.9 | 6.9 | · | 4.8 | |
| Quick Ratio | 5.0 | 5.0 | · | 3.6 | 3.6 | 3.2 | · | 3.2 | 3.4 | 3.4 | · | 3.8 | 4.8 | 6.7 | · | 4.7 | |
| Debt / Equity | -1.0 | 0.9 | · | 0.2 | 0.1 | 0.1 | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | 0.8 | · | 0.2 | 0.1 | 0.1 | · | · | · | · | · | · | · | · | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.09 | $0.09 | · | $0.54 | $0.70 | $0.95 | · | $1.21 | $1.55 | $1.86 | · | $1.93 | $2.34 | $2.20 | · | $3.09 | |
| Revenue / Share | $0.03 | $0.01 | · | $0.03 | $0.08 | $0.04 | · | $0.16 | $0.16 | $0.17 | · | $0.11 | $0.67 | $0.20 | · | $0.18 | |
| Cash Flow / Share | · | $-0.45 | · | · | · | $-0.61 | · | · | · | $-0.65 | · | · | · | $-0.58 | · | · | |
| Cash / Share | $0.54 | $0.69 | · | $0.71 | $0.44 | $0.38 | · | $0.38 | $0.49 | $0.75 | · | $1.21 | $1.57 | $2.35 | · | $2.25 | |
| EPS (TTM) | $-1.10 | $-1.19 | · | $-1.07 | $-1.16 | $-1.26 | · | $-1.71 | $-1.81 | $-1.39 | · | $-1.70 | $-1.73 | $-1.63 | · | $-1.66 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14M | $18M | · | $69M | $81M | $88M | · | $62M | $55M | $96M | · | $96M | $102M | $126M | · | $133M | |
| Net Income TTM | $-118M | $-125M | · | $-108M | $-115M | $-123M | · | $-158M | $-161M | $-121M | · | $-141M | $-143M | $-135M | · | $-136M | |
| Market Cap | $224M | $239M | · | $318M | $142M | $123M | · | $456M | $442M | $580M | · | $545M | $504M | $516M | · | $776M | |
| Enterprise Value | $61M | $42M | · | $37M | $-156M | $-222M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -1.8 | -1.8 | · | -2.8 | -1.2 | -1.0 | · | -2.7 | -2.5 | -4.3 | · | -3.8 | -3.5 | -3.8 | · | -5.7 | |
| P/S | 16.2 | 13.0 | · | 4.6 | 1.7 | 1.4 | · | 7.4 | 8.0 | 6.0 | · | 5.7 | 4.9 | 4.1 | · | 5.8 | |
| P/B | -22.5 | 23.0 | · | 5.5 | 2.0 | 1.3 | · | 3.8 | 2.9 | 3.2 | · | 3.4 | 2.6 | 2.8 | · | 3.1 | |
| P / Tangible Book | · | 23.0 | · | 5.5 | 2.0 | 1.3 | · | 3.8 | 2.9 | 3.2 | · | 3.4 | 2.6 | 2.8 | · | 3.1 | |
| P / Cash Flow | · | -4.8 | · | · | · | -2.0 | · | · | · | -9.5 | · | · | · | -10.6 | · | · | |
| EV / Revenue | 4.4 | 2.3 | · | 0.5 | -1.9 | -2.5 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -54.7% | -55.4% | · | -36.1% | -82.9% | -102.4% | · | -36.7% | -39.9% | -23.1% | · | -26.2% | -28.8% | -26.3% | · | -17.5% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $21M | $101M | $97M | $134M | $207M |
| Betriebsgewinnmarge % | -741.3% | -144.1% | -156.3% | -103.2% | -18.0% |
| Nettoergebnis | $-143M | $-119M | $-130M | $-133M | $-36M |
| Verwässerte EPS | $-1.39 | $-1.23 | $-1.56 | $-1.62 | $-0.45 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.3 | 0.1 | · | · | · |
| Liquiditätsgrad | 3.8 | 3.4 | 3.2 | 7.7 | 5.4 |
| Quick Ratio | 3.7 | 3.3 | 3.1 | 7.6 | 5.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-184M | $-231M | $-187M | $-24M | $295M |
Institutionelle Eigentümer (13F) 154 Einreicher · $189.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
154
Gehaltener Wert
$189.3M
Neue Positionen
19
Geschlossene Positionen
8
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 19 (-10 vs. Vorquartal) | 8 (-10 vs. Vorquartal) | 59 (+15 vs. Vorquartal) | 34 (-2 vs. Vorquartal) | +4.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| TCG Crossover Management, LLC | $20.100.000 | 10.000.000 | 10,62% | Aktien |
| BlackRock, Inc. | $15.774.236 | 7.847.879 | 8,33% | Aktien |
| VANGUARD GROUP INC | $10.776.564 | 6.908.054 | 5,69% | Aktien |
| Nantahala Capital Management, LLC | $8.679.399 | 4.318.109 | 4,58% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.058.773 | 4.009.340 | 4,26% | Aktien |
| Kynam Capital Management, LP | $7.655.073 | 3.808.494 | 4,04% | Aktien |
| Merck & Co., Inc. | $7.126.896 | 3.545.719 | 3,76% | Aktien |
| Balyasny Asset Management L.P. | $6.527.326 | 3.247.426 | 3,45% | Aktien |
| 683 Capital Management, LLC | $6.432.000 | 3.200.000 | 3,40% | Aktien |
| D. E. Shaw & Co., Inc. | $5.949.566 | 2.959.983 | 3,14% | Aktien |
| ADAR1 Capital Management, LLC | $5.796.002 | 2.883.583 | 3,06% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5.669.191 | 2.820.493 | 2,99% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $4.934.077 | 2.454.271 | 2,61% | Aktien |
| Spruce Street Capital LP | $4.223.147 | 2.101.068 | 2,23% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $3.997.558 | 1.988.835 | 2,11% | Aktien |
| Ikarian Capital, LLC | $3.985.038 | 1.982.606 | 2,10% | Aktien |
| STATE STREET CORP | $3.778.328 | 1.879.765 | 2,00% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.549.517 | 1.765.929 | 1,87% | Aktien |
| MEDICI CAPITAL LLC | $3.321.565 | 1.652.520 | 1,75% | Aktien |
| Affinity Asset Advisors, LLC | $3.035.100 | 1.510.000 | 1,60% | Aktien |
| Eversept Partners, LP | $2.861.985 | 1.423.873 | 1,51% | Aktien |
| FMR LLC | $2.806.759 | 1.396.398 | 1,48% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.632.249 | 1.309.577 | 1,39% | Aktien |
| Euclidean Capital LLC | $2.628.795 | 1.307.858 | 1,39% | Aktien |
| MACKENZIE FINANCIAL CORP | $2.230.638 | 1.109.770 | 1,18% | Aktien |
| DEUTSCHE BANK AG\ | $2.207.760 | 1.098.388 | 1,17% | Aktien |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $2.120.936 | 1.055.192 | 1,12% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.101.206 | 1.045.376 | 1,11% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.879.684 | 935.166 | 0,99% | Aktien |
| DAFNA Capital Management LLC | $1.825.786 | 908.351 | 0,96% | Aktien |
| Elmind Capital, LP | $1.809.000 | 900.000 | 0,96% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $1.700.458 | 845.999 | 0,90% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.645.850 | 818.831 | 0,87% | Aktien |
| NORTHERN TRUST CORP | $1.554.659 | 773.462 | 0,82% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.333.820 | 663.592 | 0,70% | Aktien |
| MARSHALL WACE, LLP | $1.203.105 | 598.559 | 0,64% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $1.071.029 | 532.850 | 0,57% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.016.808 | 651.800 | 0,54% | Aktien |
| Balyasny Asset Management L.P. | $1.012.839 | 503.900 | 0,53% | Kaufoption |
| New Leaf Venture Partners, L.L.C. | $1.005.124 | 339.569 | 0,53% | Aktien |
| GOLDMAN SACHS GROUP INC | $872.089 | 433.875 | 0,46% | Aktien |
| XTX Topco Ltd | $803.359 | 399.681 | 0,42% | Aktien |
| CITADEL ADVISORS LLC | $786.376 | 391.232 | 0,42% | Aktien |
| CANTOR FITZGERALD, L. P. | $593.939 | 295.492 | 0,31% | Aktien |
| UBS Group AG | $550.298 | 273.780 | 0,29% | Aktien |
| Invesco Ltd. | $516.849 | 257.139 | 0,27% | Aktien |
| Bank of New York Mellon Corp | $502.688 | 250.093 | 0,27% | Aktien |
| AMERIPRISE FINANCIAL INC | $451.305 | 224.530 | 0,24% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $402.000 | 200.000 | 0,21% | Aktien |
| LMR Partners LLP | $402.000 | 200.000 | 0,21% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×10 Einreichungen | 16. Juli 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 22 Insider · 11 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Arnon Rosenthal | Chief Executive Officer | 3. September 2026 S | 2.294.600 | 0 | 4 | $-655.369 |
| Neil Lindsay Berkley | CFO & Chief Business Officer | 3. September 2026 S | 350.649 | 0 | 4 | $-220.535 |
| Marc Grasso | Chief Financial Officer | 2. Juni 2025 S | 296.072 | 0 | 0 | $0 |
| Sara Kenkare-Mitra | President and Head of R&D | 3. Dezember 2025 S | 501.652 | 0 | 1 | $-46.689 |
| Shehnaaz Suliman | President and COO | 13. Dezember 2021 M | 102.598 | 0 | 0 | $0 |
| Grace Wong-Sarad | Principal Accounting Officer | 4. September 2026 S | 106.015 | 0 | 12 | $-99.033 |
| Gary Romano | Chief Medical Officer | 3. März 2025 S | 332.977 | 0 | 0 | $0 |
| Robert King | Chief Development Officer | 1. Oktober 2022 A | 550.871 | 0 | 0 | $0 |
| Robert Paul | Chief Medical Officer | 9. August 2021 M | 234.319 | 0 | 0 | $0 |
| Calvin Yu | Vice President, Finance | 6. Juli 2021 M | 76.686 | 0 | 0 | $0 |
| Sabah Oney | Chief Business Officer | 1. Oktober 2020 A | 573.918 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | Direktor | 17. Juni 2026 A | 118.650 | 0 | 0 | $0 |
| Paula Hammond | Direktor | 17. Juni 2026 A | 103.609 | 0 | 0 | $0 |
| Kristine Yaffe | Direktor | 17. Juni 2026 A | 124.109 | 0 | 0 | $0 |
| Mark Altmeyer | Direktor | 17. Juni 2026 A | 98.650 | 0 | 0 | $0 |
| Richard H Scheller | Direktor | 17. Juni 2026 A | 134.899 | 0 | 0 | $0 |
| Louis J Lavigne JR | Direktor | 17. Juni 2026 A | 128.109 | 0 | 0 | $0 |
| Errol B Desouza | Direktor | 17. Juni 2026 A | 98.650 | 0 | 0 | $0 |
| David M. Wehner | Direktor | 12. Juni 2024 A | 115.330 | 0 | 0 | $0 |
| Terrance McGuire | Direktor | 11. September 2023 S | 10.853.817 | 0 | 0 | $0 |
| Tillman U. Gerngross | Direktor | 14. Juni 2023 A | 2.644.319 | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 10. Mai 2019 A | 203.200 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 18 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,42% | 53.037 SH | 1. Oktober 2026 | Täglich |
| UAE · iShares Trust | 0,41% | 3.282.337 SH | 11. September 2026 | Täglich |
| IBRN · iShares Trust | 0,18% | 6.349 SH | 11. September 2026 | Täglich |
| IWC · iShares Trust | 0,05% | 336.837 SH | 11. September 2026 | Täglich |
| EEMS · iShares, Inc. | 0,02% | 212.007 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 820.921 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 155.185 SH | 1. Oktober 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 563.396 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 94.277 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 2.501.663 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 3.867 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16.616 SH | 3. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.071.545 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.837.922 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.493 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.223 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 230.061 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 160.282 SH | 11. September 2026 | Täglich |
ALEC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 14 Analysten
KAUF
Median-Ziel
$2.00
+10,5%
3 21,4%
Starker Kauf
5 35,7%
Kauf
4 28,6%
Halten
2 14,3%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-10-02Mittelwert-Ziel $3.10 +71,3%
Jetzt
Aktueller Preis $1.81
Tief$1.00
Mittelwert$3.10
Hoch$6.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026